Molecular Profiling Reveals Low- and High-Grade Forms of Primary Melanoma
Authors:
- Katja HarbstKHKatja Harbst
- Johan StaafJSJohan Staaf
- Anna KarlssonAKAnna Karlsson
- Anna MåsbäckAMAnna Måsbäck
- Iva JohanssonIJIva Johansson
- Pär-Ola BendahlPBPär-Ola Bendahl
- Johan Vallon-ChristerssonJVJohan Vallon-Christersson
- Henrik EkedahlHEHenrik Ekedahl
- Jürgen GeislerJGJürgen Geisler
- Mattias HöglundMHMattias Höglund
Open Access
- 30 July 2012
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 18 (15) , 4026-4036
Abstract
Purpose: For primary melanomas, tumor thickness, mitotic rate, and ulceration are well-laid cornerstones of prognostication. However, a molecular exposition of melanoma aggressiveness is critically missing. We recently uncovered a four-class structure in metastatic melanoma, which predicts outcome and informs biology. This raises the possibility that a molecular structure exists even in the early stages of melanoma and that molecular determinants could underlie histophenotype and eventual patient outcome. Experimental Design: We subjected 223 archival primary melanomas to a horizontally integrated analysis of RNA expression, oncogenic mutations at 238 lesions, histomorphometry, and survival data. Results: Our previously described four-class structure that was elucidated in metastatic lesions was evident within the expression space of primary melanomas. Because these subclasses converged into two larger prognostic and phenotypic groups, we used the metastatic lesions to develop a binary subtype-based signature capable of distinguishing between “high” and “low” grade forms of the disease. The two-grade signature was subsequently applied to the primary melanomas. Compared with low-grade tumors, high-grade primary melanomas were significantly associated with increased tumor thickness, mitotic rate, ulceration (all P < 0.01), and poorer relapse-free (HR = 4.94; 95% CI, 2.84–8.59), and overall (HR = 3.66; 95% CI, 2.40–5.58) survival. High-grade melanomas exhibited elevated levels of proliferation and BRCA1/DNA damage signaling genes, whereas low-grade lesions harbored higher expression of immune genes. Importantly, the molecular-grade signature was validated in two external gene expression data sets. Conclusions: We provide evidence for a molecular organization within melanomas, which is preserved across all stages of disease. Clin Cancer Res; 18(15); 4026–36. ©2012 AACR.Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging DatabaseJournal of Clinical Oncology, 2011
- Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanomaOncogene, 2011
- Patterns of Expression of DNA Repair Genes and Relapse From MelanomaClinical Cancer Research, 2010
- Genetic and morphologic features for melanoma classificationPigment Cell & Melanoma Research, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survivalProceedings of the National Academy of Sciences, 2009
- Gene Expression Profiling of Paraffin-Embedded Primary Melanoma Using the DASL Assay Identifies Increased Osteopontin Expression as Predictive of Reduced Relapse-Free SurvivalClinical Cancer Research, 2009
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Research, 2008
- High expression of DNA repair pathways is associated with metastasis in melanoma patientsOncogene, 2007
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI: Journal of the National Cancer Institute, 1989